Invitae Corporation (NVTA) News
Filter NVTA News Items
NVTA News Results
|Loading, please wait...|
NVTA News Highlights
- For NVTA, its 30 day story count is now at 18.
- Over the past 30 days, the trend for NVTA's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about NVTA are DX, JLL and AL.
Latest NVTA News From Around the Web
Below are the latest news stories about Invitae Corp that investors may wish to consider to help them evaluate NVTA as an investment opportunity.
Invitae Corporation (NVTA) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Jack Finks – Investor Relations Sean George – Chief Executive Officer Roxi Wen – Chief Financial Officer Ken Knight – Chief Operating Officer Conference Call Participants Dan Brennan – Cowen Chad Wiatrowski – SVB...
Invitae (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the fourth quarter and year ended December 31, 2021.
Will earnings matter for these 5 trending stocks?
In this article, we discuss the 10 stocks that Cathie Wood is doubling down on despite losses. If you want to skip our detailed analysis of these stocks, go directly to Cathie Wood is Doubling Down on These 5 Stocks Despite Losses. The prospect of rising interest rates has pushed investors to sell risky offerings […]
In this article, we discuss 10 genomics stocks in Cathie Wood’s portfolio that are underperforming. If you want to skip our detailed analysis of these stocks, go directly to 5 Genomics Stocks in Cathie Wood’s Portfolio That Are Underperforming. ARK Investment Management is an innovation-focused hedge fund that is headquartered in St. Petersburg, Florida, with […]
Invitae (NYSE: NVTA), a leading medical genetics company, today announced the availability of FusionPlex Dx® and LiquidPlex Dx™ in Europe, part of its industry-leading Anchored Multiplex PCR chemistry in-vitro diagnostic (IVD) products. Invitae is delivering essential high quality innovation for precision oncology in the fight against cancer.
Invitae to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 24, 2022
Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its fourth quarter and full year 2021 financial results on Thursday, February 24, 2022, and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.
Invitae (NVTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Troy, NY, based Investment company Fagan Associates, Inc. (Current Portfolio) buys Marvell Technology Inc, Chevron Corp, Coinbase Global Inc, JPMorgan Equity Premium Income ETF, FedEx Corp, sells International Business Machines Corp, Bristol-Myers Squibb Co, Delta Air Lines Inc, Norwegian Cruise Line Holdings, Invitae Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Fagan Associates, Inc..
The biggest winners in commercial real estate in the Triangle were the owners and developers of flex and warehouse properties as their product was in shortest supply and highest demand in 2021.